
Biodesix BDSX
$ 13.35
1.68%
Quarterly report 2025-Q3
added 11-03-2025
Biodesix Historical Prices 2011-2026 | BDSX
Annual Historical Prices Biodesix
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.71 | 1.61 | 1.73 | 5.29 | 20.2 | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 20.2 | 0.71 | 5.9 |
Historical Prices of other stocks in the Diagnostics research industry
| Issuer | Historical Prices | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
0.38 | - | -6.23 % | $ 30.6 M | ||
|
Agilent Technologies
A
|
139 | $ 117.31 | 1.94 % | $ 35.7 B | ||
|
Aspira Women's Health
AWH
|
0.39 | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
0.35 | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
0.39 | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
0.74 | - | - | $ 9.42 M | ||
|
DermTech
DMTK
|
1.3 | - | -11.32 % | $ 2.94 M | ||
|
CareDx, Inc
CDNA
|
18.6 | $ 16.76 | 4.39 % | $ 893 M | ||
|
Interpace Biosciences
IDXG
|
1.66 | $ 2.2 | -4.35 % | $ 9.73 M | ||
|
Akumin
AKU
|
0.84 | - | -17.87 % | $ 25.9 M | ||
|
Enzo Biochem
ENZ
|
1.13 | - | -8.98 % | $ 14.8 K | ||
|
Co-Diagnostics
CODX
|
4.4 | $ 1.44 | 5.11 % | $ 1.92 M | ||
|
Exact Sciences Corporation
EXAS
|
103 | - | - | $ 19.8 B | ||
|
Accelerate Diagnostics
AXDX
|
0.49 | - | -61.36 % | $ 2.46 M | ||
|
Castle Biosciences
CSTL
|
25.5 | $ 23.52 | 1.69 % | $ 653 M | ||
|
Global Cord Blood Corporation
CO
|
2.5 | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
1.44 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
0.87 | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
155 | $ 177.53 | 1.05 % | $ 8.8 B | ||
|
Medpace Holdings
MEDP
|
449 | $ 498.33 | 0.97 % | $ 14.4 B | ||
|
Myriad Genetics
MYGN
|
4.42 | $ 4.6 | 5.63 % | $ 426 M | ||
|
Danaher Corporation
DHR
|
210 | $ 195.23 | 2.99 % | $ 139 B | ||
|
NeoGenomics
NEO
|
11.6 | $ 7.96 | 3.51 % | $ 1.02 B | ||
|
Heska Corporation
HSKA
|
81.6 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
3.36 | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
103 | $ 126.4 | 4.52 % | $ 20.1 B | ||
|
Fulgent Genetics
FLGT
|
15.4 | $ 15.33 | 6.2 % | $ 464 M | ||
|
Guardant Health
GH
|
107 | $ 81.93 | 4.24 % | $ 10.3 B | ||
|
QIAGEN N.V.
QGEN
|
38.3 | - | - | $ 10.6 B | ||
|
Senseonics Holdings
SENS
|
8.4 | $ 6.69 | 0.15 % | $ 279 M | ||
|
Anixa Biosciences
ANIX
|
3.19 | $ 2.84 | 5.58 % | $ 92.2 K | ||
|
Biomerica
BMRA
|
3.13 | $ 2.09 | -1.88 % | $ 4.8 M | ||
|
Invitae Corporation
NVTA
|
2.17 | - | - | $ 21.2 M | ||
|
Koninklijke Philips N.V.
PHG
|
32 | $ 28.55 | 0.87 % | $ 20 B | ||
|
ICON Public Limited Company
ICLR
|
201 | $ 109.57 | 2.58 % | $ 9.04 B | ||
|
Soleno Therapeutics
SLNO
|
41 | $ 52.66 | 0.05 % | $ 2.68 B | ||
|
Laboratory Corporation of America Holdings
LH
|
287 | $ 264.34 | 1.31 % | $ 22 B | ||
|
Natera
NTRA
|
53.9 | $ 200.92 | 4.08 % | $ 19.8 B | ||
|
Celcuity
CELC
|
115 | $ 119.65 | 2.14 % | $ 5.59 B | ||
|
Lantheus Holdings
LNTH
|
75.9 | $ 81.32 | 0.91 % | $ 5.49 B | ||
|
Motus GI Holdings
MOTS
|
0.64 | - | -34.28 % | $ 263 K | ||
|
Neuronetics
STIM
|
1.23 | $ 1.39 | 2.59 % | $ 91.7 M | ||
|
Quest Diagnostics Incorporated
DGX
|
210 | $ 191.77 | 0.13 % | $ 21.3 B | ||
|
Neogen Corporation
NEOG
|
4.7 | $ 9.34 | -0.9 % | $ 2.03 B | ||
|
ENDRA Life Sciences
NDRA
|
4.65 | $ 5.19 | 5.06 % | $ 4.08 M | ||
|
Organovo Holdings
ONVO
|
2.12 | - | -2.3 % | $ 19.4 M | ||
|
OpGen
OPGN
|
1.96 | - | -16.95 % | $ 1.54 M |